Patents by Inventor John R. Gasdaska

John R. Gasdaska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120220015
    Abstract: Compositions and methods for producing aglycosylated plasminogen (PLG) polypeptides and fragments and variants thereof are provided. Compositions of the invention include isolated nucleic acid molecules encoding aglycosylated PLG polypeptides in which the asparagine (Asn) residue corresponding to residue Asn-289 of the mature human PLG polypeptide has been substituted with an amino acid residue that does not support N-linked glycosylation at that position of the PLG polypeptide, as well as the aglycosylated PLG polypeptides encoded thereby. Expression constructs comprising these PLG-encoding nucleic acid molecules and transgenic plants comprising these expression constructs are also provided. Methods of the invention comprise introducing a PLG-encoding nucleic acid molecule of the invention into a plant of interest and culturing the plant under conditions to produce the aglycosylated PLG polypeptide.
    Type: Application
    Filed: May 26, 2010
    Publication date: August 30, 2012
    Applicant: BIOLEX THERAPEUTICS
    Inventors: Lynn F. Dickey, John R. Gasdaska, Kevin M. Cox
  • Patent number: 8017836
    Abstract: The present invention provides methods and compositions for the production of recombinant plasminogen, microplasminogen, and fragments thereof in a duckweed expression system. It is the novel finding of the present invention that a duckweed expression system may be used to produce high levels of plasminogen and microplasminogen. The duckweed-produced plasminogen and microplasminogen can be activated to produce a polypeptide having protease activity. Thus, the invention encompasses methods for the expression of plasminogen, microplasminogen, and fragments thereof in duckweed, duckweed plants that are transformed with expression cassettes for the expression of plasminogen, microplasminogen, and fragments thereof, and nucleic acids comprising nucleotide sequences encoding plasminogen, microplasminogen, and fragments thereof, where these nucleotide sequences are modified to enhance their expression in duckweed.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: September 13, 2011
    Assignee: Biolex Therapeutics, Inc.
    Inventors: David Spencer, Lynn F. Dickey, John R. Gasdaska, Xiaowei Wang, Kevin M. Cox, Charles G. Peele
  • Publication number: 20100186126
    Abstract: The present invention provides methods and compositions for the production of recombinant plasminogen, microplasminogen, and fragments thereof in a duckweed expression system. It is the novel finding of the present invention that a duckweed expression system may be used to produce high levels of plasminogen and microplasminogen. The duckweed-produced plasminogen and microplasminogen can be activated to produce a polypeptide having protease activity. Thus, the invention encompasses methods for the expression of plasminogen, microplasminogen, and fragments thereof in duckweed, duckweed plants that are transformed with expression cassettes for the expression of plasminogen, microplasminogen, and fragments thereof, and nucleic acids comprising nucleotide sequences encoding plasminogen, microplasminogen, and fragments thereof, where these nucleotide sequences are modified to enhance their expression in duckweed.
    Type: Application
    Filed: December 22, 2009
    Publication date: July 22, 2010
    Applicant: BIOLEX THERAPEUTICS, INC.
    Inventors: DAVID SPENCER, LYNN F. DICKEY, JOHN R. GASDASKA, XIAOWEI WANG, KEVIN M. COX, CHARLES G. PEELE
  • Patent number: 7659445
    Abstract: The present invention provides methods and compositions for the production of recombinant plasminogen, microplasminogen, and fragments thereof in a duckweed expression system. It is the novel finding of the present invention that a duckweed expression system may be used to produce high levels of plasminogen and microplasminogen. The duckweed-produced plasminogen and microplasminogen can be activated to produce a polypeptide having protease activity. Thus, the invention encompasses methods for the expression of plasminogen, microplasminogen, and fragments thereof in duckweed, duckweed plants that are transformed with expression cassettes for the expression of plasminogen, microplasminogen, and fragments thereof, and nucleic acids comprising nucleotide sequences encoding plasminogen, microplasminogen, and fragments thereof, where these nucleotide sequences are modified to enhance their expression in duckweed.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: February 9, 2010
    Assignee: Biolex Therapeutics, Inc.
    Inventors: David Spencer, Lynn F. Dickey, John R. Gasdaska, Xiaowei Wang, Kevin M. Cox, Charles G. Peele
  • Patent number: 7632983
    Abstract: Methods, nucleic acid sequences, and transformed duckweed plant or duckweed nodule cultures for the expression and the secretion of biologically active polypeptides from genetically engineered duckweed are provided. Expression of recombinant polypeptides in duckweed is improved by modifying the nucleotide sequence of the expression cassette encoding the polypeptide for improved expression in duckweed. Recovery of biologically active polypeptides from duckweed is improved by linking the biologically active polypeptide to a signal peptide that directs the secretion of the polypeptide into the culture medium. Methods of producing recombinant monoclonal antibodies having effector function, and antibodies produced by these methods are provided.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: December 15, 2009
    Assignee: Biolex Therapeutics, Inc.
    Inventors: Lynn F. Dickey, John R. Gasdaska, Kevin M. Cox, Charles G. Peele, David Spencer
  • Publication number: 20040261148
    Abstract: Methods, nucleic acid sequences, and transformed duckweed plant or duckweed nodule cultures for the expression and the secretion of biologically active polypeptides from genetically engineered duckweed are provided. Expression of recombinant polypeptides in duckweed is improved by modifying the nucleotide sequence of the expression cassette encoding the polypeptide for improved expression in duckweed. Recovery of biologically active polypeptides from duckweed is improved by linking the biologically active polypeptide to a signal peptide that directs the secretion of the polypeptide into the culture medium. Methods of producing recombinant monoclonal antibodies having effector function, and antibodies produced by these methods are provided.
    Type: Application
    Filed: March 5, 2004
    Publication date: December 23, 2004
    Applicant: Biolex, Inc.
    Inventors: Lynn F. Dickey, John R. Gasdaska, Kevin M. Cox, Charles G. Peele, David Spencer